Cargando…
Amoxicillin/clavulanic-acid/azithromycin/lopinavir/ritonavir: Treatment failure following off label use and drug exposure during third trimester of pregnancy: case report
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8872882/ http://dx.doi.org/10.1007/s40278-022-10459-0 |
Ejemplares similares
-
Azithromycin/lopinavir/ritonavir: Acute kidney injury following off label use: case report
Publicado: (2021) -
Azithromycin/hydroxychloroquine/lopinavir/ritonavir: Brugada-like ECG pattern following off-label use: case report
Publicado: (2021) -
Lopinavir/ritonavir: Third-degree atrioventricular block following off-label use: case report
Publicado: (2020) -
Comparative trial between the use of amoxicillin and amoxicillin
clavulanate in the removal of third molars
por: Iglesias-Martín, Fernando, et al.
Publicado: (2014) -
Lopinavir/ritonavir: Hyperlipidaemia following off-label use: case report
Publicado: (2020)